C. Bailey

The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase.

Lisa L. Smith, I. Hickson, G. Smith, 2009, Bioorganic & medicinal chemistry letters.

Identification and optimisation of novel and selective small molecular weight kinase inhibitors of mTOR.

I. Hickson, G. Smith, G. Hermann, 2009, Bioorganic & medicinal chemistry letters.

Inhibition of the tissue factor/factor VIIa complex — Lead optimisation using combinatorial chemistry

M. Bradley, P. Roussel, A. Cross, 1999 .

Amidine protection for solution phase library synthesis

P. Kane, Emma L. Baker, C. Bailey, 1999 .

Cation-dependent transition between the quadruplex and Watson-Crick hairpin forms of d(CGCG3GCG).

C. C. Hardin, C C Hardin, T Watson, 1992, Biochemistry.

1-substituted (Dibenzo[b,d]thiophen-4-yl)-2-morpholino-4H-chromen-4-ones endowed with dual DNA-PK/PI3-K inhibitory activity.

N. Curtin, I. Hardcastle, R. Griffin, 2013, Journal of medicinal chemistry.

DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype.

N. Curtin, I. Hardcastle, R. Griffin, 2010, Journal of medicinal chemistry.

The discovery and optimisation of pyrido[2,3-d]pyrimidine-2,4-diamines as potent and selective inhibitors of mTOR kinase.

Lisa L. Smith, I. Hickson, G. Smith, 2009, Bioorganic & medicinal chemistry letters.